CIBC Bancorp USA’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
CIBC Bancorp USA's BMY Position: Q2 2026 in Review
CIBC Bancorp USA reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q2 2026, selling an estimated $6M and leaving 601,653 shares worth $34.7M. The position accounts for 0.04% of the portfolio, ranked #311.
CIBC Bancorp USA first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $42.8M in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- CIBC Bancorp USA held 601,653 shares of Bristol-Myers Squibb worth $34.7M as of Q2 2026.
- CIBC Bancorp USA sold 104,455 Bristol-Myers Squibb shares in Q2 2026, an estimated $6M.
- Bristol-Myers Squibb made up 0.04% of CIBC Bancorp USA's portfolio in Q2 2026, its #311 holding.
- CIBC Bancorp USA first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
- CIBC Bancorp USA's Bristol-Myers Squibb position peaked at $42.8M in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.